Skip to main content

Table 1 Patient characteristics

From: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study

Category

Age in months median (range)

71 (1–207)

Sex (male [M]: female [F])

93 M:62 F

Diagnosis

Patients number

Delay in chemotherapy: median (range)

Acute lymphoblastic leukemia (ALL)

52

13 (0–105)

CNS tumor

30

14 (0–60)

Soft tissue sarcoma (STS)

16

12 (0–26)

Neuroblastoma

15

15 (0–44)

Hodgkin lymphoma (HL)

10

12 (0–15)

Renal tumor

8

17 (12–19)

Acute myeloid leukemia (AML)

7

17 (0–56)

Non-Hodgkin lymphoma (NHL)

4

17 (0–20)

Osteosarcoma

4

7 (0–14)

Retinoblastoma

2

7 (n/a)

Other (EWS, GCT, HCC, LCH, NET, SPN)

7

14 (10–27)

  1. CNS, central nervous system; EWS, Ewing’s sarcoma; GCT, germ cell tumor; HCC, hepatocellular carcinoma; LCH, Langerhans histiocytosis; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm